Heart Disease Clinical Trials in San Francisco

Showing 141-160 of 283 trials

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

NCT04669548

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Intraabdominal HypertensionAbdominal Compartment SyndromeAcute Kidney Injury+1 more

Potrero Medical2,500 participantsStarted Dec 2020

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +6 more locations

COMPLETEDNA< 1 mile

Clinical Utility Trial for the SomaLogic CVD-T2D Test

NCT05237271

QURE will use its CPV technology in a randomized controlled trial to measure how SomaLogic's diagnostic test (the Cardiovascular Disease in Type 2 Diabetes) changes clinical practice and improves patient outcomes.

Cardiovascular DiseasesType 2 Diabetes

Qure Healthcare, LLC251 participantsStarted Mar 2022

San Francisco, California, United States

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Clinical Utility Trial for the SomaLogic CVD-T2D Test

Heart Disease Trials in Other Cities

Dynamic Cardiac SPECT Imaging

MOMENTUM 3 IDE Clinical Study Protocol

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Cardiac Recovery Through Dietary Support

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

Randomized Endo-Vein Graft Prospective

A Digital Flu Intervention for People With Cardiovascular Conditions

The Product Surveillance Registry REVERSE Post Approval Study

The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)

Incidental Coronary Calcification Quality Improvement Project

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

SHIELD II Clinical Investigation

Restore EF Observational Study

Other Conditions in San Francisco